PMID- 28382326 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220409 IS - 2364-3722 (Print) IS - 2196-9736 (Electronic) IS - 2196-9736 (Linking) VI - 5 IP - 4 DP - 2017 Apr TI - International multicenter comparative trial of endoscopic ultrasonography-guided gastroenterostomy versus surgical gastrojejunostomy for the treatment of malignant gastric outlet obstruction. PG - E275-E281 LID - 10.1055/s-0043-101695 [doi] AB - Background and study aims EUS-guided gastroenterostomy (EUS-GE) is a novel procedure that potentially offers long-lasting luminal patency without the risk of tumor ingrowth/overgrowth. This study compared the clinical success, technical success, adverse events (AEs), length of hospital stay (LOHS) and symptom recurrence in EUS-GE versus SGJ. Methods This was a multicenter international retrospective comparative study of EUS-GE and SGJ in patients with malignant gastric outlet obstruction (GOO) who underwent either EUS-GE or SGJ. EUS-GE was performed using lumen apposing metal stents. Results A total of 93 patients with malignant GOO treated with either EUS-GE (n = 30) or SGJ (n = 63) were identified. Peritoneal carcinomatosis was present in 13 (43 %) patients in the EUS-GE group and 7 (11 %) patients in the SGJ group (P < 0.001). Although the technical success rate was significantly higher in the SGJ group as compared to the EUS-GE group (100 % vs. 87 %, P = 0.009), the clinical success rate was not different (90 % vs. 87 %, P = 0.18, OR 0.8, 95 %CI 0.44 - 7.07). The rate of AEs was lower in the EUS-GE group, but the difference was not statistically significant (16 % vs 25 %, P = 0.3). The mean LOHS was similar in the EUS-GE group compared to SGJ (P = 0.35). The rate of recurrent GOO was not different between the two groups (3 % vs. 14 %, P = 0.08). Similarly, the mean time to reintervention was similar (88 days vs. 121 days, P = 0.83). Conclusions EUS-GE is associated with equivalent efficacy and safety as compared to surgical GJ. This is the first comparative trial between both techniques and suggests EUS-GE as a non-inferior but less invasive alter to surgery. FAU - Khashab, Mouen A AU - Khashab MA AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Bukhari, Majidah AU - Bukhari M AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Baron, Todd H AU - Baron TH AD - Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, United States. FAU - Nieto, Jose AU - Nieto J AD - Borland-Groover Clinic, Jacksonville, Florida, United States. FAU - El Zein, Mohamad AU - El Zein M AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Chen, Yen-I AU - Chen YI AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Chavez, Yamile Haito AU - Chavez YH AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Ngamruengphong, Saowanee AU - Ngamruengphong S AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Alawad, Ahmad S AU - Alawad AS AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Kumbhari, Vivek AU - Kumbhari V AD - Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States. FAU - Itoi, Takao AU - Itoi T AD - Division of Gastroenterology and Hepatology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan. LA - eng PT - Journal Article PL - Germany TA - Endosc Int Open JT - Endoscopy international open JID - 101639919 PMC - PMC5378550 COIS- Competing interests Mouen Khashab is a consultant for Boston Scientific. Todd Baron is a consultant for Boston Scientific. Jose Nieto is a consultant for Boston Scientific. Takao Itoi is a consultant for Boston Scientific EDAT- 2017/04/07 06:00 MHDA- 2017/04/07 06:01 PMCR- 2017/04/01 CRDT- 2017/04/07 06:00 PHST- 2017/04/07 06:00 [entrez] PHST- 2017/04/07 06:00 [pubmed] PHST- 2017/04/07 06:01 [medline] PHST- 2017/04/01 00:00 [pmc-release] AID - 10.1055/s-0043-101695 [doi] PST - ppublish SO - Endosc Int Open. 2017 Apr;5(4):E275-E281. doi: 10.1055/s-0043-101695.